1. Home
  2. NMTC vs EKSO Comparison

NMTC vs EKSO Comparison

Compare NMTC & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$4.55

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$11.80

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
EKSO
Founded
2009
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.5M
37.9M
IPO Year
2010
2012

Fundamental Metrics

Financial Performance
Metric
NMTC
EKSO
Price
$4.55
$11.80
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$11.90
$9.50
AVG Volume (30 Days)
111.2K
34.3K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
80.43
41.76
EPS
N/A
N/A
Revenue
$9,097,692.00
N/A
Revenue This Year
N/A
$81.23
Revenue Next Year
$31.90
$7.29
P/E Ratio
N/A
N/A
Revenue Growth
163.47
N/A
52 Week Low
$0.55
$0.23
52 Week High
$5.40
$13.50

Technical Indicators

Market Signals
Indicator
NMTC
EKSO
Relative Strength Index (RSI) 65.13 60.17
Support Level $0.69 $8.30
Resistance Level $5.40 $12.39
Average True Range (ATR) 0.28 0.86
MACD -0.12 0.15
Stochastic Oscillator 24.60 79.44

Price Performance

Historical Comparison
NMTC
EKSO

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Share on Social Networks: